Rapid onset of intranasal esketamine in patients with treatment resistance depression and major depression with suicide ideation: a meta-analysis - Wang SM, Kim NY, Na HR, Lim HK, Woo YS, Pae CU, Bahk WM.

OBJECTIVE: We performed a meta-analysis of randomized double-blinded placebo controlled trials (DB-RCTs) to investigate efficacy and safety of intranasal esketamine in treating major depressive disorder (MDD) including treatment resistant depression (TRD) ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news